Clinical Trials Search at Vanderbilt-Ingram Cancer Center

CY 6022 - A FOLLOW-UP, OPEN-LABEL, RESEARCH EVALUATION OF SUSTAINED TREATMENT WITH AFICAMTEN (CK-3773274) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)

Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD)

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension

TAVR Low Risk & CAS - Transcatheter Aortic Valve Replacement (TAVR) in Patients with the Medtronic Transcatheter Aortic Valve Replacement System (TAVR) in Patients at Low Risk for Surgical Aortic Valve Replacement (SAVR) Continued Access Trial

Aday, Aaron/Novartis Pharmaceuticals Corporation/ (CADPT15A12201)

Occluflex - Prospective randomized multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Figulla Flex II PFO Occluder to standard of care PFO occlusion.

Genetics of Appendix Cancer: The GAP Study

Colon

The RADIANCE-HTN; Study A study of the ReCor Medical Paradise System in Clinical Hypertension

SPYRAL AFFIRM IDE-G150036

Open-Label, Long-Term Safety and Efficacy Study of Mim8 in Participants with Haemophilia A with or without Inhibitors